Services
FUNDRAISING
M&A
LICENSING
STRATEGIC CONSULTING
Transactions
Team
News
Contact
Transactions
Acticor Biotech obtains “PRIME” status from the European Medicines Agency for glenzocimab in the treatment of stroke
Show more
Introductions : Acticor, 20 ME à lever
Show more
Success of Acticor Biotech’s Initial Public Offering on the Euronext Growth® market, with €15.5 million raised
Show more
Acticor Biotech Announces the Completion of Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study
Show more
FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial
Show more
FineHeart Successfully Tests the Implantable, Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS Heart Pump
Show more